Phyu Thin Naing

Assistant Professor in hematology/oncology at #Vanderbilt #WIM Views are my own

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Check our viewpoint published @JAMA_current #MedEd

Abstract Factory—Research Culture Harming Medical Education

The "abstract factory" is destroying medical education. Trainees and junior faculty compete with abstract counts instead of meaningful research. Result: inflated CVs, diluted conferences. We shouldn't celebrate this—you don't need publications to be a great doctor.

➡️https://t.co/IMBhy45L1K

@utswcancer @rajshekharucms @HiraSMian @ManniMD1 @HemOncFellows @ASCOTECAG

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

#ASH25 saying it louder for everyone in the back!

If you are starting a bsAb in #MMsm (especially BCMA), don’t wait for patient to die or IgG to drop. Start IgRT now!

Newest case in point: excellent IFM 2021-01 trial. Only 14% Gr3+ infxns despite older pts & CD38 pair!

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

Excellent #ASH25 @ASH_hematology article by @bdermanmd about MRD-guided discontinuation of #MMsm maintenance therapy based on data we have currently (while we await SWOG S1803).

I've been doing 2 years of len maintenance before these discussions... maybe I should start at 1!

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

#ASH25 @AlfredChung11 updated AURIGA focused on MRD dynamics, including MRD resurgence ( ➖ ➡️➕).

Similar to IMROZ data last year by @Myeloma_Doc ... MRD resurgence less common with continued CD38 pressure, even in HR. Another argument in favor of its inclusion in maintenance!

[Phyu Thin Naing @PhyuNaing4]

I want to share an opinion piece on ASCO Connection that was written as I reflected on my fellowship experiences. Being in the field of oncology has been a journey full of lessons and questions. I look forward to more learning moments ahead. https://t.co/uUYfQo5ZXT

[Phyu Thin Naing @PhyuNaing4]

First time attending and presenting at #AACR meeting.
I’m inspired by all the emerging scientific work presented here! #AACR25

[ASH @ASH_hematology]

Because 👏 science 👏saves 👏 lives👏

So amazing to see the community come together today! ASH is here to protect science and push for the research funding that leads to breakthroughs. 💪🩸

[Phyu Thin Naing @PhyuNaing4]

Glad to present the work on racial disparities in social deprivation index and multiple myeloma outcomes.
It was also a great opportunity to connect with friends and mentors at #ASH2024

[Jennifer A. Marks, MD @jennifermarksmd]

Hopefully these algorithms for the treatment of #breastcancer make your life a little easier. @NCCN were a bit confusing for me. These incorporate several resources for your non-breast onc docs. #bcsm #MedTwitter #OncTwitter
Check out @IlanaSchlam algorithms and @asco guidelines

[Phyu Thin Naing @PhyuNaing4]

A great learning experience @AACR/ @ASCO Methods in Clinical Cancer Research Workshop. A humbling experience to meet outstanding faculty and fellows of oncology!

[Vijaya R Bhatt, MBBS, MS @VijayaRBhatt1]

@ASCO @AACR Methods in Clinical Cancer Research 2024- it is so much fun interacting with this group of talented scholars and faculty members! @DrJulieVose

[Phyu Thin Naing @PhyuNaing4]

Sharing a piece of my experience as an IMG on Hematopoiesis, a trainee newsletter.

[Richa Thakur, MD @RichaThakurMD]

Check out this amazing poster on how decreasing venetoclax exposure and increasing the length of cycle in AML can improve mOS and mPFS! @EdZhou1 @PhyuNaing4 @DrDavidChitty @BradleyGoldber4(Poster #4268) #ASH23 @NorthwellHealth

[Phyu Thin Naing @PhyuNaing4]

@RichaThakurMD @ASH_hematology Looking forward to Fellows game night!!

[Richa Thakur, MD @RichaThakurMD]

Come check out this amazing poster! #ASHKudos to @PhyuNaing4 for creating this amazing NIVE tool to help predict infection-related deaths, EFS, and OS in AML patients. @NorthwellHealth @BradleyGoldber4 @DrDavidChitty @EdZhou1 #ASH23

[Phyu Thin Naing @PhyuNaing4]

A good way to pass through a long TSA line - check ASH Image Bank flashcards!
#ASH2023 #ashimagebank

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

Been hearing from several of my double vaccinated and boosted friends who were at #ASCO22 and now positive for COVID 😔- wishing everyone a speedy recovery 🙏

[ACS Journal Cancer @JournalCancer]

There is a growing need for diversity, equity, & inclusion (DEI) in cancer care, esp. w/ respect to equal access & accrual to #ClinicalTrials. This new commentary by @JustinekahnMD et al proposes actions to improve DEI in clinical trials: https://t.co/MQjD0HDXsq @OSUCCC_James

[Jared Dyer, DO @DrJaredDyer]

#MRPearls Do not forget to check the delta-delta ratio in the presence of a high anion gap metabolic acidosis to determine if there is a coexisting normal anion gap metabolic acidosis or metabolic alkalosis. @VCU_IMRes @AudreyBJernigan @JCHillyard @jkidd03